These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11888934)

  • 1. Activation of the Erk mitogen-activated protein kinase pathway stimulates neuroendocrine differentiation in LNCaP cells independently of cell cycle withdrawal and STAT3 phosphorylation.
    Kim J; Adam RM; Freeman MR
    Cancer Res; 2002 Mar; 62(5):1549-54. PubMed ID: 11888934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-6- and cyclic AMP-mediated signaling potentiates neuroendocrine differentiation of LNCaP prostate tumor cells.
    Deeble PD; Murphy DJ; Parsons SJ; Cox ME
    Mol Cell Biol; 2001 Dec; 21(24):8471-82. PubMed ID: 11713282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of cholesterol-rich lipid rafts in interleukin-6-induced neuroendocrine differentiation of LNCaP prostate cancer cells.
    Kim J; Adam RM; Solomon KR; Freeman MR
    Endocrinology; 2004 Feb; 145(2):613-9. PubMed ID: 14563701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-6 induces neuroendocrine dedifferentiation and cell proliferation in non-small cell lung cancer cells.
    Chang KT; Tsai CM; Chiou YC; Chiu CH; Jeng KS; Huang CY
    Am J Physiol Lung Cell Mol Physiol; 2005 Sep; 289(3):L446-53. PubMed ID: 15894558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-6-induced STAT3 transactivation and Ser727 phosphorylation involves Vav, Rac-1 and the kinase SEK-1/MKK-4 as signal transduction components.
    Schuringa JJ; Jonk LJ; Dokter WH; Vellenga E; Kruijer W
    Biochem J; 2000 Apr; 347 Pt 1(Pt 1):89-96. PubMed ID: 10727406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells.
    Badache A; Hynes NE
    Cancer Res; 2001 Jan; 61(1):383-91. PubMed ID: 11196191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
    Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EGF prevents the neuroendocrine differentiation of LNCaP cells induced by serum deprivation: the modulator role of PI3K/Akt.
    Martín-Orozco RM; Almaraz-Pro C; Rodríguez-Ubreva FJ; Cortés MA; Ropero S; Colomer R; López-Ruiz P; Colás B
    Neoplasia; 2007 Aug; 9(8):614-24. PubMed ID: 17898861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ErbB kinases and NDF signaling in human prostate cancer cells.
    Grasso AW; Wen D; Miller CM; Rhim JS; Pretlow TG; Kung HJ
    Oncogene; 1997 Nov; 15(22):2705-16. PubMed ID: 9400997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoactive intestinal peptide induces neuroendocrine differentiation in the LNCaP prostate cancer cell line through PKA, ERK, and PI3K.
    Gutiérrez-Cañas I; Juarranz MG; Collado B; Rodríguez-Henche N; Chiloeches A; Prieto JC; Carmena MJ
    Prostate; 2005 Apr; 63(1):44-55. PubMed ID: 15468165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genistein-induced neuroendocrine differentiation of prostate cancer cells.
    Pinski J; Wang Q; Quek ML; Cole A; Cooc J; Danenberg K; Danenberg PV
    Prostate; 2006 Aug; 66(11):1136-43. PubMed ID: 16652383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The functional synergy between IL-12 and IL-2 involves p38 mitogen-activated protein kinase and is associated with the augmentation of STAT serine phosphorylation.
    Gollob JA; Schnipper CP; Murphy EA; Ritz J; Frank DA
    J Immunol; 1999 Apr; 162(8):4472-81. PubMed ID: 10201984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signaling through PI3K/Akt mediates stretch and PDGF-BB-dependent DNA synthesis in bladder smooth muscle cells.
    Adam RM; Roth JA; Cheng HL; Rice DC; Khoury J; Bauer SB; Peters CA; Freeman MR
    J Urol; 2003 Jun; 169(6):2388-93. PubMed ID: 12771803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 6 activates androgen receptor-mediated gene expression through a signal transducer and activator of transcription 3-dependent pathway in LNCaP prostate cancer cells.
    Chen T; Wang LH; Farrar WL
    Cancer Res; 2000 Apr; 60(8):2132-5. PubMed ID: 10786674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of epidermal growth factor receptor induces sequestration of extracellular signal-related kinases and selective attenuation of specific epidermal growth factor-mediated signal transduction pathways.
    Habib AA; Chun SJ; Neel BG; Vartanian T
    Mol Cancer Res; 2003 Jan; 1(3):219-33. PubMed ID: 12556561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-6 triggers cell growth via the Ras-dependent mitogen-activated protein kinase cascade.
    Ogata A; Chauhan D; Teoh G; Treon SP; Urashima M; Schlossman RL; Anderson KC
    J Immunol; 1997 Sep; 159(5):2212-21. PubMed ID: 9278309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-beta1 transcriptionally activates CD34 and prevents induced differentiation of TF-1 cells in the absence of any cell-cycle effects.
    Marone M; Scambia G; Bonanno G; Rutella S; de Ritis D; Guidi F; Leone G; Pierelli L
    Leukemia; 2002 Jan; 16(1):94-105. PubMed ID: 11840268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor induces hypertrophic responses and Stat5 activation in rat ventricular cardiomyocytes.
    Rebsamen MC; Arrighi JF; Juge-Aubry CE; Vallotton MB; Lang U
    J Mol Cell Cardiol; 2000 Apr; 32(4):599-610. PubMed ID: 10756117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-beta1 (TGF-beta)-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-beta-activated kinase 1 and mitogen-activated protein kinase kinase 3.
    Edlund S; Bu S; Schuster N; Aspenström P; Heuchel R; Heldin NE; ten Dijke P; Heldin CH; Landström M
    Mol Biol Cell; 2003 Feb; 14(2):529-44. PubMed ID: 12589052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The phosphatidylinositol 3'-kinase pathway is a dominant growth factor-activated cell survival pathway in LNCaP human prostate carcinoma cells.
    Lin J; Adam RM; Santiestevan E; Freeman MR
    Cancer Res; 1999 Jun; 59(12):2891-7. PubMed ID: 10383151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.